Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc.
Categories
Biotechnology
About
Lipella is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of lipid-based therapies for common bladder syndromes including interstitial cystitis (IC), refractory overactive bladder (OAB), and hemorrhagic cystitis (HC).
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – biotechnology and diagnostic companies, medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.